$SVRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Savara Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Savara Inc. Get notifications about new insider transactions in Savara Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2008 | MSTX | Mast Therapeutics, ... | Schupp Joachim PH | VP, Medical Affairs | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Apr 02 2008 | MSTX | Mast Therapeutics, ... | Keran Patrick L | VP, Legal and Gener ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Apr 02 2008 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | SVP & Chief Science ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Apr 02 2008 | MSTX | Mast Therapeutics, ... | Culley Brian M | SVP & Chief Busines ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Mar 26 2008 | MSTX | Mast Therapeutics, ... | Denner Alexander J | Director | Option Exercise | A | 0.48 | 50,000 | 24,000 | 100,000 | |
Mar 25 2008 | MSTX | Mast Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 0.48 | 50,000 | 24,000 | 50,000 | |
Dec 17 2007 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & Director | Buy | P | 0.48 | 10,000 | 4,800 | 60,000 | 50 K to 60 K (+20.00 %) |
Dec 17 2007 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & Director | Buy | P | 0.44 | 50,000 | 22,000 | 50,000 | 0 to 50 K |
Dec 17 2007 | MSTX | Mast Therapeutics, ... | MERRITT JAMES A | President & Chf Med ... | Buy | P | 0.48 | 2,058 | 988 | 35,000 | 32.9 K to 35 K (+6.25 %) |
Dec 17 2007 | MSTX | Mast Therapeutics, ... | MERRITT JAMES A | President & Chf Med ... | Buy | P | 0.44 | 27,942 | 12,294 | 32,942 | 5 K to 32.9 K (+558.84 %) |
Sep 11 2007 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | CSO, Sr. VP | Sell | S | 2.30 | 8,000 | 18,400 | 146,500 | 154.5 K to 146.5 K (-5.18 %) |
Aug 03 2007 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | CSO, Exec VP | Sell | S | 2.35 | 8,000 | 18,800 | 154,500 | 162.5 K to 154.5 K (-4.92 %) |
May 29 2007 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Option Exercise | A | 2.57 | 50,000 | 128,500 | 50,000 | |
May 25 2007 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 2.57 | 50,000 | 128,500 | 50,000 | |
May 25 2007 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | A | 2.57 | 50,000 | 128,500 | 50,000 | |
May 25 2007 | MSTX | Mast Therapeutics, ... | Bagnall Mark | Director | Option Exercise | A | 2.57 | 50,000 | 128,500 | 50,000 | |
May 25 2007 | MSTX | Mast Therapeutics, ... | Denner Alexander J | Director | Option Exercise | A | 2.57 | 50,000 | 128,500 | 50,000 | |
Jan 17 2007 | MSTX | Mast Therapeutics, ... | Cantwell Mark Joseph | VP, Research & Deve ... | Option Exercise | A | 2.75 | 25,000 | 68,750 | 25,000 | |
Jan 17 2007 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | Senior VP and CS0 | Option Exercise | A | 2.75 | 75,000 | 206,250 | 75,000 | |
Jan 17 2007 | MSTX | Mast Therapeutics, ... | Schupp Joachim PH | VP, Medical Affairs | Option Exercise | A | 2.75 | 50,000 | 137,500 | 50,000 | |
Jan 17 2007 | MSTX | Mast Therapeutics, ... | Culley Brian M | SVP & Chief Busines ... | Option Exercise | A | 2.75 | 150,000 | 412,500 | 150,000 | |
Jan 17 2007 | MSTX | Mast Therapeutics, ... | MERRITT JAMES A | President & Chf Med ... | Option Exercise | A | 2.75 | 33,333 | 91,666 | 33,333 | |
Jan 17 2007 | MSTX | Mast Therapeutics, ... | Keran Patrick L | VP, Legal & General ... | Option Exercise | A | 2.75 | 50,000 | 137,500 | 50,000 | |
Dec 21 2006 | MSTX | Mast Therapeutics, ... | JOHNSON M ROSS | Director | Option Exercise | X | 0.49 | 502,528 | 246,239 | 0 | |
Dec 21 2006 | MSTX | Mast Therapeutics, ... | JOHNSON M ROSS | Director | Payment of Exercise | F | 2.57 | 95,813 | 246,239 | 1,621,779 | 1.7 M to 1.6 M (-5.58 %) |
Dec 21 2006 | MSTX | Mast Therapeutics, ... | JOHNSON M ROSS | Director | Buy | X | 0.49 | 502,528 | 246,239 | 1,717,592 | 1.2 M to 1.7 M (+41.36 %) |
Dec 21 2006 | MSTX | Mast Therapeutics, ... | HANSON GREGORY P | Senior VP, CFO & Tr ... | Option Exercise | A | 2.57 | 250,000 | 642,500 | 250,000 | |
Oct 17 2006 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | X | 1.25 | 6,000 | 7,500 | 0 | |
Oct 17 2006 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Buy | X | 1.25 | 6,000 | 7,500 | 26,000 | 20 K to 26 K (+30.00 %) |
Sep 29 2006 | MSTX | Mast Therapeutics, ... | MERRITT JAMES A | President & Chf Med ... | Option Exercise | A | 2.86 | 300,000 | 858,000 | 300,000 | |
Sep 29 2006 | MSTX | Mast Therapeutics, ... | LIEF JACK | Director | Option Exercise | A | 2.86 | 50,000 | 143,000 | 50,000 | |
Aug 21 2006 | MSTX | Mast Therapeutics, ... | Keran Patrick L | General Counsel | Option Exercise | A | 2.99 | 100,000 | 299,000 | 100,000 | |
Aug 21 2006 | MSTX | Mast Therapeutics, ... | Schupp Joachim PH | VP, Medical Affairs | Option Exercise | A | 2.99 | 100,000 | 299,000 | 100,000 | |
Jun 30 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Option Exercise | X | 0.50 | 25,000 | 12,500 | 0 | |
Jun 30 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Buy | X | 0.50 | 25,000 | 12,500 | 4,320,000 | 4.3 M to 4.3 M (+0.58 %) |
Jun 27 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Option Exercise | X | 0.50 | 25,000 | 12,500 | 0 | |
Jun 27 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Buy | X | 0.50 | 25,000 | 12,500 | 4,270,000 | 4.2 M to 4.3 M (+0.59 %) |
Jun 28 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Option Exercise | X | 0.50 | 25,000 | 12,500 | 0 | |
Jun 28 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Buy | X | 0.50 | 25,000 | 12,500 | 4,295,000 | 4.3 M to 4.3 M (+0.59 %) |
Jun 23 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Option Exercise | X | 0.50 | 25,000 | 12,500 | 0 | |
Jun 23 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Buy | X | 0.50 | 25,000 | 12,500 | 4,245,000 | 4.2 M to 4.2 M (+0.59 %) |
Jun 06 2006 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Option Exercise | A | 4.62 | 50,000 | 231,000 | 50,000 | |
Jun 06 2006 | MSTX | Mast Therapeutics, ... | JOHNSON M ROSS | Director | Option Exercise | A | 4.62 | 50,000 | 231,000 | 50,000 | |
Jun 06 2006 | MSTX | Mast Therapeutics, ... | Bagnall Mark | Director | Option Exercise | A | 4.62 | 50,000 | 231,000 | 50,000 | |
Jun 06 2006 | MSTX | Mast Therapeutics, ... | GOLDBERG MICHAEL M | Director | Option Exercise | A | 4.62 | 50,000 | 231,000 | 50,000 | |
Jun 06 2006 | MSTX | Mast Therapeutics, ... | Meister Keith | Director | Option Exercise | A | 4.62 | 50,000 | 231,000 | 50,000 | |
Apr 25 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Option Exercise | X | 0.50 | 25,601 | 12,801 | 0 | |
Apr 25 2006 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President & CEO | Buy | X | 0.50 | 25,601 | 12,801 | 4,220,000 | 4.2 M to 4.2 M (+0.61 %) |
Feb 02 2006 | MSTX | Mast Therapeutics, ... | Carlander Carrie | CFO, Treas, Secy, V ... | Option Exercise | A | 4.75 | 80,000 | 380,000 | 80,000 | |
Feb 02 2006 | MSTX | Mast Therapeutics, ... | Culley Brian M | VP, Business Develo ... | Option Exercise | A | 4.75 | 80,000 | 380,000 | 80,000 | |
Feb 02 2006 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | CSO, Exec. VP | Option Exercise | A | 4.75 | 100,000 | 475,000 | 100,000 | |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Option Exercise | X | 0.50 | 54,399 | 27,200 | 125,601 | |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Buy | X | 0.50 | 54,399 | 27,200 | 4,194,399 | 4.1 M to 4.2 M (+1.31 %) |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Sell | S | 3.50 | 28,100 | 98,350 | 4,140,000 | 4.2 M to 4.1 M (-0.67 %) |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Sell | S | 3.60 | 19,599 | 70,556 | 4,168,100 | 4.2 M to 4.2 M (-0.47 %) |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Sell | S | 3.61 | 1,100 | 3,971 | 4,187,699 | 4.2 M to 4.2 M (-0.03 %) |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Sell | S | 3.62 | 4,600 | 16,652 | 4,188,799 | 4.2 M to 4.2 M (-0.11 %) |
Sep 14 2005 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | President and CEO | Sell | S | 3.64 | 1,000 | 3,640 | 4,193,399 | 4.2 M to 4.2 M (-0.02 %) |
Jun 15 2005 | MSTX | Mast Therapeutics, ... | Carlander Carrie | CFO, Treasurer, VP ... | Buy | P | 2.90 | 5,000 | 14,500 | 25,000 | 20 K to 25 K (+25.00 %) |
May 31 2005 | MSTX | Mast Therapeutics, ... | Carlander Carrie | CFO, Treasurer, VP ... | Buy | P | 2.25 | 5,000 | 11,250 | 20,000 | 15 K to 20 K (+33.33 %) |
May 18 2005 | MSTX | Mast Therapeutics, ... | Carlander Carrie | CFO, Treasurer, VP ... | Buy | P | 2.45 | 5,000 | 12,250 | 15,000 | 10 K to 15 K (+50.00 %) |
May 02 2005 | MSTX | Mast Therapeutics, ... | Carlander Carrie | CFO, Treasurer, VP ... | Buy | P | 2.45 | 5,000 | 12,250 | 10,000 | 5 K to 10 K (+100.00 %) |
Apr 25 2005 | MSTX | Mast Therapeutics, ... | Habita Cellia | Senior VP, Clinical ... | Buy | P | 1.10 | 5,000 | 5,500 | 5,000 | 0 to 5 K |
Apr 18 2005 | MSTX | Mast Therapeutics, ... | Carlander Carrie | CFO, Treasurer, VP ... | Buy | P | 2.38 | 5,000 | 11,900 | 5,000 | 0 to 5 K |
Apr 07 2005 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Buy | P | 1.70 | 2,400 | 4,080 | 3,000 | 600 to 3 K (+400.00 %) |
Apr 07 2005 | MSTX | Mast Therapeutics, ... | PYKETT MARK JEROME | Director | Buy | P | 1.69 | 600 | 1,014 | 600 | 0 to 600 |
Mar 24 2004 | MSTX | Mast Therapeutics, ... | VIRCA NICHOLAS J | CEO and President | Option Exercise | X | 0.49 | 29,435 | 14,423 | 0 | |
Mar 24 2004 | MSTX | Mast Therapeutics, ... | VIRCA NICHOLAS J | CEO and President | Buy | X | 0.00 | 15,698 | 0 | 347,956 | 332.3 K to 348 K (+4.72 %) |
Mar 23 2004 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | Chief Technical Off ... | Option Exercise | J | 0.50 | 37,500 | 18,750 | 337,500 | |
Mar 23 2004 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | Chief Technical Off ... | Buy | J | 0.40 | 125,000 | 50,000 | 125,000 | 0 to 125 K |
Mar 23 2004 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | Chief Technical Off ... | Option Exercise | J | 0.50 | 37,500 | 18,750 | 337,500 | |
Mar 23 2004 | MSTX | Mast Therapeutics, ... | ROBBINS JOAN M | Chief Technical Off ... | Buy | J | 0.40 | 125,000 | 50,000 | 125,000 | 0 to 125 K |